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Abstract
Background: Both ageing and hypertension are known risk factors for atrial fibrillation (AF) although the pathophysiological
contribution or interaction of the individual factors remains poorly understood. Here we aim to delineate the
arrhythmogenic atrial substrate in mature spontaneously hypertensive rats (SHR).
Methods: SHR were studied at 12 and 15 months of age (n = 8 per group) together with equal numbers of age-matched
normotensive Wistar-Kyoto control rats (WKY). Electrophysiologic study was performed on superfused isolated right and left
atrial preparations using a custom built high-density multiple-electrode array to determine effective refractory periods (ERP),
atrial conduction and atrial arrhythmia inducibility. Tissue specimens were harvested for structural analysis.
Results: Compared to WKY controls, the SHR demonstrated: Higher systolic blood pressure (p,0.0001), bi-atrial
enlargement (p,0.05), bi-ventricular hypertrophy (p,0.05), lower atrial ERP (p = 0.008), increased atrial conduction
heterogeneity (p = 0.001) and increased atrial interstitial fibrosis (p = 0.006) & CD68-positive macrophages infiltration
(p,0.0001). These changes resulted in higher atrial arrhythmia inducibility (p = 0.01) and longer induced AF episodes
(p = 0.02) in 15-month old SHR. Ageing contributed to incremental bi-atrial hypertrophy (p,0.01) and atrial conduction
heterogeneity (p,0.01) without affecting atrial ERP, fibrosis and arrhythmia inducibility. The limited effect of ageing on the
atrial substrate may be secondary to the reduction in CD68-positive macrophages.
Conclusions: Significant atrial electrical and structural remodeling is evident in the ageing spontaneously hypertensive rat
atria. Concomitant hypertension appears to play a greater pathophysiological role than ageing despite their compounding
effect on the atrial substrate. Inflammation is pathophysiologically linked to the pro-fibrotic changes in the hypertensive
atria.
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Introduction
Both ageing and hypertension are known risk factors for atrial
fibrillation (AF). Epidemiological studies have established that the
odds ratio for developing AF was 2.1–2.2 and 1.4–1.5 for each
decade of advancing age and hypertension respectively. [1] While
the presence of multiple risk factors is likely to increase the
susceptibility and persistence of AF, the pathophysiological
contribution or interaction of the individual factors remains
poorly understood. [2,3] Several studies had characterized the
substrate for AF in hypertension or ageing individually, but the
compounding effect of ageing and hypertension on the atria has
not been studied in detail.
The spontaneously hypertensive rat (SHR) is most commonly
used in high blood pressure research to represent established
human hypertension, with the Wistar Kyoto rat (WKY) as the
normotensive control. [4] However, due to the difficulty in
performing detailed high density direct contact electrophysiolog-
ical mapping study in rat atria and the long-held belief that small
atria do not fibrillate according to the ‘‘critical mass’’ hypothesis,
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limited high density atrial mapping data is available from the SHR
model [5–8]. Recently, we reported on the feasibility of high
density multiple-electrode array (MEA) contact mapping studies of
superfused small animal atria. [9] Here, we aimed to comprehen-
sively evaluate the atrial electrical and structural remodeling
predisposing to AF in ageing SHR with established hypertension
using a custom-built high density MEA system and structural
analysis.
Methods
This study was approved by the Animal Ethics Committee of
the University of Adelaide, Adelaide, Australia (Approval Number
S-078-07). All animal experimentations conformed to the ‘Guide
for the Care and Use of Laboratory Animals’ as adopted by
National Institutes of Health, USA and all efforts were made to
minimize suffering. A total of 32 male rats were included in this
study: 16 were SHR and 16 were normotensive WKY control rats
at 12 and 15 months of age (n = 8 per time point). The SHR
(lifespan 18–30 months; 50% of this colony survive for 21 months)
develops hypertension from 2–3 months of age which peaks from 6
months of age onwards with increasing compensatory concentric
cardiac hypertrophy, before the onset of heart failure at the age of
15–18 months. [4,10,11] The time-points of 12 and 15 months
were chosen to allow characterization of the atrial substrate due to
established hypertension with maximal left ventricular hypertro-
phy in mature rats, based on the well-characterized blood pressure
and cardiovascular profile of the SHR model prior to the
development of heart failure. [11].
All animals were given ad libitum access to food and water and
were housed in temperature-controlled rooms with 12 h light/
dark cycle. For experimentations, they were first anesthetized with
intra-peritoneal injection of ketamine (60 mg/kg) and medetomi-
dine (0.5 mg/kg). Systolic blood pressure was then measured non-
invasively using an inflatable tail-cuff and pressure transducer in
conjunction with a PowerLab system (MLT125/R cuff/transducer
and ML125 NIBP controller, ADInstruments, New South Wales,
Australia). At least three measurements were performed and the
average taken. Transthoracic echocardiography (Vivid 7 with
10 MHz transducer, GE Healthcare, Buckinghamshire, United
Kingdom) was used to determine left ventricular wall thickness
and systolic fractional shortening from M-mode measurements at
the level of the papillary muscles with atria dimensions measured
from the apical 4-chamber view. [12] The heart was removed via a
midline thoracotomy incision and placed in ice-cold modified
HEPES buffer containing in mM (134 NaCl, 4 KCl,
1.2 NaH2PO4, 1.2 MgSO4, 11 glucose and 10 HEPES-NaOH).
Both right and left atria were then carefully dissected from the
heart for immediate electrophysiological studies.
Electrophysiological Study
Detailed information about the MEA system setup (Nucleus
Medical, Adelaide, Australia) has been described previously. [9] In
brief, the MEA measures 464.5 mm and consists of 90 silver
chloride electrodes of 0.1 mm diameter with 0.5 mm inter-
electrode distance. The atrial tissue was placed over the MEA
and superfused with modified HEPES solution (pH 7.35) and
bubbled with 100% oxygen. 1 mM of 2,3-butanedione monoxime
was added to suppress contraction artifacts together with 1.5 mM
of CaCl2. The superfusate was circulated in a closed loop using a
peristaltic pump (Minipuls 3, Gilson Inc., Middleton, USA) and its
temperature regulated at 37.5uC with a heater. A lightweight mesh
was placed over the tissue to ensure constant tissue contact with
the underlying electrodes. The MEA was connected to a
computerized recording system (LabSystem Pro, Bard Electro-
physiology, Lowell, USA) with a sampling rate of 4 kHz and
filtering from 10–500 Hz. For consistency, the atrial tissues were
placed over the MEA in the same cranial-caudal and medial-
lateral orientation with the epicardial surface in contact with the
electrodes.
Atrial effective refractory period. Atrial effective refracto-
ry period (ERP) was measured at twice diastolic threshold from
two sites in each atrium – RA free wall (RAFW), RA appendage
(RAA), LA free wall (LAFW) and LA appendage (LAA). This was
performed with eight basic (S1) stimuli at 400, 300, 200 and
100 ms followed by a premature (S2) stimulus in 5 ms decrement.
Refractoriness was defined as the longest S1–S2 interval not
resulting in a propagated response. A total of three ERP
measurements were taken from each site at each cycle length
and the total averaged. The coefficient of ERP variation (standard
deviation/mean6100%) was determined to assess ERP heteroge-
neity.
Atrial conduction. Conduction was assessed during stable S1
pacing at 400, 300, 200 and 100 ms from 2 pre-specified opposing
corners of the MEA. Activation maps were created using semi-
automated custom-made plaque analysis software (Nucleus Med-
ical, Adelaide, Australia). Each annotation was manually verified
with the local activation time annotated to the peak of the largest
amplitude deflection on bipolar electrograms. Conduction velocity
was calculated from local vectors within each triangle of electrodes
to derive a mean conduction velocity for each activation map.
[13].
Conduction heterogeneity. Conduction heterogeneity was
assessed using an established phase mapping method during S1
pacing. [14] In brief, the largest activation time difference between
every four adjacent electrodes was first determined. This was then
used to create a phase map, with values also displayed as a
histogram. Absolute conduction phase delay was taken as the
difference between the 5th from the 95th percentile of the phase
distribution (P5–95). The conduction heterogeneity index was then
obtained by dividing the absolute phase delay by the median (P50).
Arrhythmia inducibility and duration. This was assessed
with rapid decremental pacing at the atrial appendage, starting
from 100 ms cycle length, which was decreased in 5 ms intervals
every 2 seconds until either atrial tachycardia/fibrillation (AT/AF)
was initiated or there was loss of 1:1 capture. This protocol of
induction was implemented 10 times in total for determining
inducibility and duration of induced arrhythmic episodes. AT/AF
was defined as rapid regular/irregular atrial activation lasting
more than 6 beats. A normalized voltage algorithm was
implemented to visualize the wavefront propagation sequence
during atrial arrhythmia (Refer to online supplement methods S1).
Structural Analysis
Following electrophysiological studies, the atrial tissues were
immersed fixed with 10% neutralized buffered formalin and
paraffin embedded for subsequent light microscopic evaluation.
To assess the morphology of atrial myocytes, tissue sections were
stained with haematoxylin and eosin (H&E) stain. Measurement of
mean myocyte cross-sectional area was performed as previously
described. [15] In brief, only myocytes with intact cellular
membranes from fields with circular capillary profiles and
myofiber shapes were assessed. In total, the circumferences of 40
to 50 cells per atrium were traced digitally to calculate mean cross-
sectional area. Sections were stained with picrosirius red to
demonstrate the extracellular matrix in a masked protocol.
Twenty random images from each atrium of every animal were
digitally scanned by Aperio Scanscope (Model CS and Image-
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Scope, Aperio Technologies, Vista, USA) and the accumulation of
matrix was quantitated by using a modification of the technique
described by Lehr et al in a blinded manner. [16] Immunostaining
was also performed with mouse anti-rat CD68 monoclonal
antibody (AbD Serotec, Raleigh, USA) for quantification of
interstitial macrophage infiltration. Macrophage number in the
interstitium of the heart was estimated by counting the number of
macrophages in 10 fields under light microscopy with a
magnification 6200 per animal from each group and expressed
as numbers per section.
Statistical Analysis
All continuous variables are reported as mean 6 SD and
assessed for normality using the Shapiro-Wilk test. To improve
presentation clarity, mean 6 standard error of the mean was
utilized in Figure 1. Data were compared using the Student’s t-test
or Wilcoxon rank sum test according to their distribution.
Categorical data was tested using Fisher’s exact statistics. A linear
mixed effects model was used to compare changes over time of
electrophysiologic data between the two groups, with hyperten-
sion, age and their interaction modeled as fixed effects and
individual animal fitted as random effect. Statistical significance
was established at P,0.05.
Results
Detailed animal characteristics are shown in Table 1. There was
no significant difference in body weight between the SHR and
WKY controls at both time-points. In these mature adult rats,
systolic blood pressure was significantly higher in the SHR as
compared to the WKY controls. In particular, systolic blood
pressure was found to be stable between 12 and 15 months of age.
Anatomical Remodeling
Significant bi-atrial hypertrophy was evident in the SHR as
assessed by echocardiography and pathological examinations
(Table 1). These atrial changes due to hypertension were
accompanied by increased inter-ventricular septal thickness and
bi-ventricular hypertrophy while left ventricular systolic function
was preserved (Table 1). However, the effect of ageing on atrial
anatomical remodeling was non-significant except when atrial
weight was indexed to body weight.
Electrophysiological Remodeling
Atrial refractoriness. Atrial ERP was significantly lower in
the SHR as compared to the WKY controls at both time points
(p = 0.008). However, in both SHR and WKY, ERP was not
significantly different between the 12 and 15 month atria (p = 0.3)
and ERP was unaltered by pacing cycle length in both groups
(p = 0.8). To illustrate the above, ERP data from the LAFW are
presented in Figure 1 (top row). However, when analyzed
according to pacing location, ERP was found to be consistently
higher in the LA as compared to the RA (Figure 1, bottom row:
data from S1 @200 ms; p,0.001). Nevertheless, overall mean
ERP heterogeneity was similar between SHR and WKY (LA:
3268 vs. 3167%, p= 0.8; RA: 1769 vs. 2362%, p= 0.2
respectively).
Atrial conduction. Figure 2 depicts the activation maps and
their corresponding phase histograms from representative LA of
WKY and SHR during pacing with S1 at 200 ms. In these maps,
isochronal lines are 2 ms apart with early to late activation
denoted by the color red to purple. Note that overall plaque
activation times are similar indicating comparable atrial conduc-
tion velocity. However, the SHR demonstrated higher conduction
Figure 1. Atrial Refractoriness. Atrial ERP was significantly lower in the SHR as compared to the WKY controls at both time points (Mean ERP from
LAFW shown in the top row). Although ERP was not affected by ageing or pacing cycle length (S1), higher ERP was seen in the LA as compared to the
RA (Mean ERP with S1 @200 ms shown in the bottom row). Error bars denote standard error of the mean.
doi:10.1371/journal.pone.0072416.g001
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heterogeneity as compared to the WKY, which were further
increased with ageing.
Indeed, neither hypertension nor ageing had any significant
effect on atrial conduction velocity (Figure 3, top row; p= 0.1 and
0.3 respectively). In contrast, the SHR atria demonstrated higher
absolute conduction heterogeneity (P5–95) and conduction het-
erogeneity index (P5–95/P50) than the WKY controls (Figure 3,
middle & bottom rows; p = 0.001 & p,0.001 respectively).
Furthermore, both P5–95 and P5–95/P50 also increased signif-
icantly in tandem with ageing (Figure 3, middle & bottom rows;
p = 0.006 & p,0.001 respectively). However, the impact of ageing
on conduction velocity, P5–95 and P5–95/P50 was similar in both
the SHR and WKY atria as evidenced by the non-significant
interaction between hypertension and age for all three parameters
(Figure 3, p = 0.1, 0.8 & 0.4 respectively).
Overall, as compared to the RA, the LA demonstrated
significantly slower conduction velocity, higher P5–95 and P5–
95/P50 (Figure 3: p,0.001, p = 0.001 & p,0.001 respectively).
Although atrial conduction was found to be progressively slower
with higher P5–95 with increasing pacing rate in both WKY and
SHR atria (Figure 3, top & middle rows; both p,0.001), P5–95/
P50 was not affected by pacing rate (Figure 3, bottom row;
p= 0.3). Nevertheless, all parameters of atrial conduction were
found to be direction dependent with higher conduction velocity
and lower conduction heterogeneity during cranial-caudal than
caudal-cranial propagation [Conduction velocity: SHR -
0.3460.06 vs. 0.2660.04 m/s, WKY - 0.3560.07 vs.
0.2760.05 m/s; p,0.001, P5–95: SHR - 12.167.0 vs.
12.764.7 ms/mm, WKY - 9.263.6 vs. 11.264.6 ms/mm;
p= 0.039, P5–95/P50: SHR - 2.2060.41 vs. 2.5260.43, WKY
–1.8960.32 vs. 1.9360.31, p,0.001; respectively].
Atrial arrhythmia. The proportion of animals with induc-
ible atrial arrhythmia following rapid decremental pacing was
higher in the SHR than WKY although this was only statistically
significant in the 15-month cohort (Figure 4, 12 month: 5/8 vs. 3/
8, p= 0.6; 15 month: 7/8 vs. 2/8, p= 0.04 respectively). Likewise,
arrhythmia inducibility was significantly higher in the 15-month
hypertensive atria as compared to WKY controls (Figure 4, left
panel). In addition, induced AT/AF episodes were significantly
more sustained in the SHR than the WKY in the 15 months old
age group (Figure 4, right panel). However, ageing had no
significant effect on both arrhythmia inducibility and duration in
both groups as demonstrated in Figure 4. Both macro-reentrant
atrial tachycardia and AF were seen in the SHR atria. (Online
supplement: Movie S1 and S2 respectively).
Structural Remodeling
The SHR atria demonstrated myocyte hypertrophy (Figure 5,
top left panel), increased interstitial fibrosis (Figure 5, middle left
panel) and CD68-positive macrophages count (Figure 5, bottom
left panel) as compared to the WKY controls. Although ageing had
no effect on atrial fibrosis, atrial myocyte size was significantly
larger and CD68-positive macrophages count was significantly
lower in both SHR and WKY with ageing. Representative
photomicrographs of H&E, picrosirius red and CD68 immuno-
stained sections from 15 month-old SHR and WKY atria are also
shown in Figure 5 (right panel).
Discussion
This high density mapping study presents detailed character-
ization of the atrial electrical and structural substrate in mature
SHR with established hypertension and left ventricular hypertro-
phy in comparison to WKY controls, to provide new insights into
the relative contribution of hypertension and ageing towards an
arrhythmogenic substrate for AF. In comparison to normotensive
WKY controls, hypertension in the SHR led to significant: i) Bi-
atrial enlargement and bi-ventricular hypertrophy; ii) Abbrevia-
tion of atrial refractoriness; iii) Increase in atrial conduction
heterogeneity & iv) Increase in atrial myocyte dimension,
Table 1. Animal Characteristics.
12 Month 15 Month
WKY SHR WKY SHR
(n=8) (n=8) (n=8) (n=8) P value{ P value`
Body wt (g) 410615 420613 420620 428613 0.1 0.2
Systolic BP (mmHg) 128616 191632 129610 197617 ,0.0001 0.6
Echocardiography
LV Fractional shortening (%) 49.963.5 50.665.6 51.463.6 53.463.3 0.5 0.3
IVS (mm) 1.460.4 2.160.2 1.560.1 2.260.2 ,0.0001 0.3
RA area (mm2) 14.861.1 15.861.9 14.161.8 16.361.2 0.03 0.9
LA area (mm2) 19.162.0 23.462.8 19.064.2 23.460.6 0.002 0.9
Pathology
Heart wt (g) 1.0860.11 1.3460.12 1.1160.07 1.4660.06 ,0.0001 0.03
RA/body wt (mg/g) 0.04360.009 0.05160.007 0.04260.013 0.06960.008 0.0001 0.009
LA/body wt (mg/g) 0.04960.011 0.05160.006 0.05560.023 0.08560.021 0.02 0.004
IVS/body wt (mg/g) 0.5760.04 0.7360.05 0.5860.14 0.7560.12 0.0002 0.8
RV free wall/body wt (mg/g) 0.4660.07 0.5060.02 0.4760.10 0.5660.05 0.02 0.3
LV free wall/body wt (mg/g) 1.5460.22 1.8360.10 1.5760.17 1.9060.13 ,0.0001 0.4
Wt – weight; BP – blood pressure; LV – left ventricular; IVS – inter-ventricular septum; RA – right atrium; LA – left atrium; RV – right ventricular.
{P value for effect due to hypertension.
`P value for effect due to age.
doi:10.1371/journal.pone.0072416.t001
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interstitial fibrosis and CD68-positive macrophages infiltration.
Together, these changes resulted in higher atrial arrhythmia
inducibility and longer induced AT/AF episodes. In the presence
of persistent hypertension and maximal left ventricular hypertro-
phy, ageing contributed to incremental bi-atrial enlargement,
atrial myocyte hypertrophy and atrial conduction heterogeneity
without affecting atrial refractoriness. Surprisingly, atrial arrhyth-
mia susceptibility/sustainability and fibrosis were not higher due
to ageing in these SHR despite the additional atrial enlargement
and conduction changes. Perhaps, the atrial remodeling attribut-
able to ageing was ameliorated by a significant reduction in CD68-
positive macrophages. Here, hypertension appears to play a
greater pathophysiological role than ageing in the remodeling of
the mature SHR atria.
Concomitant Conditions and Abnormal Atrial Substrate
It is now recognized that co-existing risk factors contribute to
both the development and progressive nature of AF. [17,18]
Specifically, ageing and hypertension have also been found to lead
to increased thromboembolic complications in patients with AF,
even though the pathophysiological contribution or interaction of
each factor remains poorly understood. [18] Individually, various
animal and human studies on the effect of ageing or hypertension
have demonstrated comparable atrial electrical and structural
remodeling. The atrial substrate due to ageing consists of
unchanged [19] or increased refractoriness or action potential
duration[20–25] with unchanged/increased dispersion,
[22,24,26,27] increased electrogram fractionation, [26,28] in-
creased delayed afterdepolarizations [24] and decreased conduc-
tion velocity. [19,21,25,26,28] In the hypertensive atria, ERP was
found to be unchanged, [5,6,29] increased,[30–32] or decreased
[7,33] with unchanged [30,31] ERP dispersion. Other hyperten-
sion-related atrial electrical changes included conduction slowing
with increased heterogeneity,[29–32] increased electrogram frac-
tionation [30,32] and increased dominant frequency. [33]
However, in a mouse model of salt-induced hypertension,
conduction velocity was not altered by hypertensive remodeling
as seen in this study. [33].
On the structural level, both ageing and hypertension were
associated with increased atrial fibrosis and myocyte hypertrophy
that could account for the electrical changes of slowed atrial
conduction, increased conduction heterogeneity and electrogram
fractionation.[5,6,19,21,29–31,33] The variability in atrial refrac-
toriness could be explained by the differences in species or models
studied and the measurement technique (in-vivo vs. in-vitro), but
the findings of increased atrial fibrosis and subsequent atrial
conduction changes appear to be universal as seen in other
arrhythmogenic substrates.[34–43] In the present study, we
identified similar electrical and structural changes in the mature
SHR atria. In addition, we were able to delineate the relative
contribution of hypertension and ageing to the abnormal atrial
substrate and demonstrate the incremental changes when the two
conditions co-exist.
Pathophysiological Role of Inflammatory Macrophages in
Atrial Remodeling
The universal morphological finding of increased atrial fibrosis
is likely to represent a final common pathway of structural
Figure 2. Representative Atrial Activation Maps. Activation maps from representative left atrium of both WKY (top row) and SHR (bottom row)
during pacing with S1 at 200 ms are shown here. Isochronal lines of 2 ms are superimposed with fixed time range from 0 to 30 ms. Overall plaque
activation times are similar indicating comparable atrial conduction velocity. However, the SHR demonstrated higher conduction heterogeneity as
compared to the WKY, which were further increased with ageing. Corresponding phase histograms of these activation maps are also shown on the
right panel of this figure.
doi:10.1371/journal.pone.0072416.g002
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remodeling that contributes to the maintenance of AF. Indeed,
several pathophysiological signaling pathways are implicated in
different structural heart diseases leading to the common
manifestations of hypertrophy and fibrosis. [3] Recent pre-clinical
studies have highlighted an inflammatory role in hypertensive
atrial remodeling that had not been well appreciated previously. In
one-kidney, one-clip large animal model, we have demonstrated
increased inflammatory cell infiltration in short term hypertension
and its significant correlation with atrial conduction abnormalities
and AF inducibility. [30,31] Kume and co-workers confirmed the
involvement of inflammatory pro-fibrotic mechanisms in a small
animal pressure overload model of hypertension due to aortic
constriction. [44] These findings corroborate well with clinical
data whereby higher C-reactive protein levels were seen in
Figure 3. Atrial Conduction. Neither hypertension nor ageing had any significant effect on atrial conduction velocity (top row). In contrast, the
SHR atria demonstrated higher absolute conduction heterogeneity (P5–95) and conduction heterogeneity index (P5–95/P50) than the WKY controls
(middle & bottom rows). Both P5–95 and P5–95/P50 also increased significantly in tandem with ageing. In addition, increased pacing rate was
associated with slower conduction velocity and higher P5–95 (top & middle rows). Significant differences were seen in all three conduction
parameters between the left and right atrium.
doi:10.1371/journal.pone.0072416.g003
Figure 4. Atrial Arrhythmia Inducibility and Duration. Hypertension resulted in greater arrhythmia inducibility (left panel) and more sustained
induced AT/AF episodes in the SHR as compared to normotensive WKY controls at 15 months (right panel). Horizontal lines denote the median values
in the scatter plot with the proportion of animals with inducible arrhythmia shown in brackets. However, ageing had no significant effect on both
parameters in both groups.
doi:10.1371/journal.pone.0072416.g004
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hypertensive patients and associated with higher AF burden and
increased risk of developing the arrhythmia.[45–47].
Furthermore, active inflammation and immune response in
human fibrillating atria have been reported with recruitment of
CD68-positive macrophages found across the atrial endocardium.
[48,49] Similarly, we found increased CD-68 positive macrophag-
es in the mature SHR atria. These macrophages are likely
initiators of atrial fibrosis through generation of reactive oxygen
species, release of cytokines, growth factors and pro-fibrotic
enzymes. [50] In addition, the significant ageing related reduction
in CD-68 positive macrophages in our study is in keeping with
human data whereby both the decline in macrophage numbers
and function are well documented with ageing. [51] Taken
together, while this could explain the relatively limited incremental
atrial remodeling due to ageing in the SHR atria, it further
highlights the important pathophysiological role of inflammation
in the hypertensive atria.
Clinical Implications
Hypertension accounts for more AF than any other risk factors
due to its high prevalence in the population. As the prevalence of
hypertension also increases with age, its arrhythmic burden is
likely to be higher in the elderly. This study unravels the relative
greater contribution of high blood pressure than ageing to the
abnormal arrhythmogenic substrate in the hypertensive atria with
established left ventricular hypertrophy. Our findings raise the
importance of strict blood pressure management in the elderly,
especially those with concomitant AF. This study also presents
evidence regarding the important pathophysiological role of
inflammatory macrophages in hypertensive atrial remodeling.
Novel agents targeting these macrophages derived inflammatory
pathways may provide alternate substrate specific upstream
therapies in the future.
Study Limitations
The SHR is the most widely studied experimental model of
hypertension. However, it remains uncertain whether we can
directly extrapolate our findings to the wide range of human
hypertensive syndromes. To facilitate high-density contact map-
ping of the atria, electrophysiological evaluations were performed
ex-vivo in the superfused atria with 2,3-butanedione monoxime
added to suppress motion artifacts. Although 2,3-butanedione
monoxime has been reported to affect a number of cardiac ion
channels, intracellular calcium levels and action potential dura-
tion, the dosage used in this study was significantly lower (order of
106) than those used in the previous reports. We did not verify
Figure 5. Atrial Structural Changes. Increased atrial myocyte dimension (Left, top panel), collagen deposition (Left, middle panel) and CD68-
positive macrophages (Left, bottom panel) were seen with hypertension. Although ageing had no effect on atrial fibrosis, atrial myocyte hypertrophy
was evident with lower CD68-positive macrophages count in both SHR and WKY with ageing. Representative H&E (Right, A & B, magnification6400),
picrosirius red (Right, C & D, magnification6200) and CD68 immuno-stained sections (Right, E & F, magnification6200) are shown to demonstrate the
atrial myocyte hypertrophy, increased amount of interstitial collagen deposition and CD68-positive macrophages in the 15 month-old SHR vs. WKY
atria.
doi:10.1371/journal.pone.0072416.g005
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that the degree of oxygenation and substrate delivery were
sufficient to meet the metabolic demands of the atrial tissues.
Placement of a lightweight mesh over the atrial tissue on the MEA
may induce mechanical stretch and affect atrial electrophysiology.
However, at no time did we observe any degradation of signals
with our MEA setup, with good tissue viability and high quality of
electrogram recordings maintained well after completion of
electrophysiological assessment. [9] Data from ex-vivo mapping
may be different from in-vivo studies. Nevertheless, we controlled
for these limitations by comparing our electrophysiologic data to
control atria studied in the same preparations. A bigger gap in the
age of the animals would have provided a better picture on the
remodeling due to ageing. Diastolic dysfunction was not assessed
but previous studies have clearly demonstrated increased diastolic
stiffness in the SHR leading to increased atrial stretch [11,52] that
may have contributed to the remodeling seen in the ageing SHR
atria described in this study.
Conclusions
Significant atrial electrical and structural remodeling was seen
with hypertension and ageing in the mature spontaneously
hypertensive rat atria. In this study, hypertension appears to play
a greater pathophysiological role than ageing. Inflammation is
likely to be mechanistically important in the pro-fibrotic cascade of
the hypertensive atria.
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Movie S1 This normalized voltage movie demonstrates
a stable counter-clockwise wavefront propagation se-
quence consistent with a macro-reentrant type atrial
tachycardia in the left atrium of a 12 month old
spontaneously hypertensive rat. Here, the signal scale
ranged from red to purple, representing normalized voltage from
0 to 1.
(WMV)
Movie S2 This normalized voltage movie shows irreg-
ularly irregular atrial wavefront propagations consis-
tent with atrial fibrillation following delivery of a
premature atrial stimulus in the left atrium of a 15
month old spontaneously hypertensive rat. Similarly, the
signal scale ranged from red to purple, representing normalized
voltage from 0 to 1.
(WMV)
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